Invention Grant
- Patent Title: Pyrimidinyl-diazospiro compounds
-
Application No.: US15646552Application Date: 2017-07-11
-
Publication No.: US10010551B2Publication Date: 2018-07-03
- Inventor: Gerard M. P. Giblin , David T. MacPherson , David R. Witty , Steven J. Stanway
- Applicant: CONVERGENCE PHARMACEUTICALS LIMITED
- Applicant Address: GB Maidenhead
- Assignee: Convergence Pharmaceuticals Limited
- Current Assignee: Convergence Pharmaceuticals Limited
- Current Assignee Address: GB Maidenhead
- Agency: Foley Hoag LLP
- Agent David P. Halstead; Lucas P. Watkins
- Priority: GB1209015.5 20120522
- Main IPC: C07D471/10
- IPC: C07D471/10 ; A61K31/506 ; A61K31/407 ; A61K31/438 ; C07D487/10
Abstract:
The invention relates to spiro deriviatives, to the use of said derivatives in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivatives and processes for their preparation.
Public/Granted literature
- US20170304303A1 Novel Pyrimidinyl-DiazoSpiro Compounds Public/Granted day:2017-10-26
Information query
